Tal Rosenberg to Lead Apollo Intelligence as New Chief Executive Officer
Apollo Intelligence (Apollo), a leading global provider of high-quality, real-time insights to the life sciences and healthcare industries, announces the appointment of Tal Rosenberg as Chief Executive Officer.
Rosenberg is a technology executive with an exceptional track record of using data and technology to transform Life Sciences businesses for both Fortune 100 and PE-backed companies. Known for inspiring teams to drive digitally-forward, customer-centric innovations, he will focus on advancing growth by expanding the capabilities and offerings of the Apollo technology platform.
Powered by artificial intelligence, Apollo directly connects clients to a highly engaged, global panel of healthcare professionals who respond to research at industry-leading rates.
“Apollo delivers on a critical need to accelerate drug development and launch effectiveness through its real-time primary market insights, and we are well-positioned to broaden our insight offerings through new data ingestion and analytics,” said Tai Rosenberg. “I am thrilled to join the team as we transform the market, bringing greater value to clients and partners.”
In his prior role as President and GM of the Life Sciences, Ecosystem and Public Sector business unit at Datavant, Rosenberg led the development of the world’s largest Real World Data (RWD) ecosystem, including a patient privacy record linkage platform. Before that, he led IQVIA Technologies, launching SaaS applications and services from molecule to market.
Rosenberg succeeds Dan Fitzgerald, Apollo’s founder and previous CEO. "Over the last five years, Apollo’s talented team has doubled revenue by delivering highly differentiated product innovation and superior client satisfaction. Tal’s leadership and deep expertise in life sciences, technology, and building transformational industry partnerships, will help drive our next phase of growth. I am thrilled that Apollo’s more than 300 clients, employees, and our future vision and success will be in such capable hands," said Fitzgerald. Dan will serve as a Board Advisor going forward to ensure a seamless transition.
To address accelerated drug launch timelines and the need for dynamic market learning, Apollo has modernized how life sciences leaders stay ahead of changing market dynamics through its mobile connected audiences and real-time insights platform.
Christina Reszka, investment partner at Frazier Healthcare Partners and board member of Apollo, shared, “The Apollo team is well-positioned to change the way the healthcare industry sources and applies primary market insights and data. We are incredibly thankful for Dan Fitzgerald's leadership, which has been a critical factor in building Apollo’s strong foundation and industry leading brand. I look forward to supporting Tal’s strategic vision for the future.”
About Apollo Intelligence
Apollo Intelligence is a leading insights platform purpose-built to drive greater impact for Life Sciences. Our panel of highly engaged, global healthcare professionals gives partners 24/7 access to some of medicine’s most relevant minds, while our mobile-first quantitative and qualitative research capabilities ensure more responsive and high-quality engagement. We combine human expertise, modern methodologies, and innovative digital tools to better connect the dots across all sources of market intelligence and give our healthcare partners the fast and focused understanding necessary to outpace change. Apollo’s family of brands include InCrowd, Survey Healthcare Global, and GlocalMind.
View source version on businesswire.com: https://www.businesswire.com/news/home/20240917612396/en/
Contacts
Nemesh Patel
VP, Marketing
Nemesh.patel@apollointelligence.net
+1-617-875-8177
Mary Kae Marinac
PR Representative for Apollo Intelligence
mk@mkmarinac.com
+1-978-685-3136
(c) 2024 Business Wire, Inc., All rights reserved.
Business Wire, a Berkshire Hathaway company, is the global leader in multiplatform press release distribution.
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
GeologicAI Announces Acquisition of Lumo Analytics to Complete Its Integrated Sensor Suite Across Critical Minerals and Rare Earth Elements17.12.2025 17:53:00 CET | Press Release
GeologicAI, the global leader in High-Resolution Decision Engineering for the critical minerals sector, today announced its acquisition of Lumo Analytics, a provider of the most compact and efficient Laser-Induced Breakdown Spectroscopy (LIBS) scanner in the market. LIBS is a rapid, non-destructive technique that uses a high-energy laser pulse to vaporize a tiny spot on a rock, creating a short-lived plasma which emits light unique to the elements present when it cools. This spectral “fingerprint” provides immediate chemical information about the material. For the mining sector, this means faster geochemical insights directly at the source, enabling more efficient exploration and resource evaluation. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20251217715846/en/ The transaction firmly cements GeologicAI’s position as the only truly comprehensive and integrated source of sensor data for the critical minerals industry. Buildi
Incyte Announces European Commission Approval of Minjuvi ® (tafasitamab) for the Treatment of Relapsed or Refractory Follicular Lymphoma17.12.2025 17:20:00 CET | Press Release
Incyte (Nasdaq:INCY) today announced that the European Commission (EC) has approved Minjuvi® (tafasitamab) in combination with lenalidomide and rituximab for the treatment of adult patients with relapsed or refractory follicular lymphoma (FL) (Grade 1-3a) after at least one line of systemic therapy. "The EC approval of Minjuvi addresses a critical need, bringing a new, first-of-its-kind, chemotherapy-free option to patients in Europe with relapsed or refractory FL,” said Bill Meury, President and Chief Executive Officer, Incyte. “Historically, FL patients have had limited treatment options in the second-line setting, and we are proud to drive this important advancement for the lymphoma community as we seek to deliver innovative medicines for patients with cancer.” The EC decision follows the positive opinion received from the European Medicines Agency’s Committee for Medicinal Products for Human Use (CHMP) in November 2025. This marks the second indication for Minjuvi, which was previo
Rigaku Launches ONYX 3200, a Metrology Instrument for Semiconductor Manufacturing17.12.2025 16:00:00 CET | Press Release
Rigaku Corporation, a global solution partner in X-ray analytical systems and a group company of Rigaku Holdings Corporation (headquarters: Akishima, Tokyo; CEO: Jun Kawakami; hereinafter “Rigaku”) announced the launch of the ONYX 3200, a new semiconductor metrology system to measure film thickness, composition and bump* structures for wafer-level processes. The system is engineered to help manufacturers stabilize quality and increase yield in the metal-wiring formation (back-end-of-line (BEOL)) and packaging processes of semiconductor chips. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20251216597402/en/ ONYX 3200 Due to accelerating demands for AI, high-performance computing, data centers, mobile devices, and other devices, chip wiring and interconnect structures have grown increasingly delicate and complex. As a result, the ability to accurately and non-destructively measure metal layers thinner than a human hair and bump
Taylor Wessing Diversifies Its International Strategy17.12.2025 15:05:00 CET | Press Release
International law firm Taylor Wessing is set to diversify its strategy within its international alliance, in order to push international growth and innovation. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20251217415857/en/ Dr. Oliver Bertram, Global Co-Chair at Taylor Wessing The English part of the partnership is seeking a merger with US law firm Winston & Strawn and would – depending on a corresponding partner decision, which is still pending – leave the Taylor Wessing alliance at the end of April 2026. Both parties wish to continue their successful joint international client work unchanged. Therefore, collaboration between Taylor Wessing and future Anglo-American firm Winston Taylor will continue seamlessly based on a cooperation agreement, ensuring that clients will not experience any change in their collaboration with Taylor Wessing. With the firm’s new open strategy, Taylor Wessing equally meets the strategic requirem
ISACA to Lead Global Credentialing for CMMC Cybersecurity Framework as International Cyber Readiness Standards Rise17.12.2025 15:00:00 CET | Press Release
As cyber threats escalate and governments raise expectations around operational resilience, ISACA has been appointed to lead the global credentialing programme for the U.S. DoW’s Cybersecurity Maturity Model Certification (CMMC) program. The appointment positions ISACA – the international association for cybersecurity, audit and digital trust – as the exclusive CMMC Assessor and Instructor Certification Organization (CAICO), responsible for training, examining and certifying professionals, assessors, and instructors across the CMMC ecosystem. Originally developed by the U.S. DoW to protect sensitive unclassified information within its global supply chain, CMMC is increasingly relevant to European defence, aerospace, engineering and high-technology companies participating in transatlantic programmes. As the framework is phased into U.S. procurement from 2025 to 2028, many European organisations that handle Controlled Unclassified Information (CUI) or Federal Contract Information (FCI),
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom